Goldenrod Therapeutics, Inc.
PrivateLast Round
Seed
May 26, 2026
Total Funding Raised
$920,000
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Goldenrod Therapeutics, Inc. operates in Healthcare & Life Sciences and is based in Houston, Texas. Its latest recorded funding round was a Grant round in November 2024.
Goldenrod Therapeutics, Inc. is a biotechnology company developing next-generation, brain-penetrant phosphodiesterase 4 (PDE4) inhibitors for serious neurological disorders.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Revenue Share, Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Goldenrod Therapeutics, Inc. Comparables
Compare Goldenrod Therapeutics, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Enthorin Therapeutics | 83% | |
| Shionogi & Co. | 74% | |
| PTC Therapeutics Inc | 69% |
For institutional investors. Book with your work email.
Goldenrod Therapeutics, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | May 26, 2026 | ||||
| Grant | Nov 5, 2024 | ||||
| Grant | Oct 10, 2024 | ||||
| Grant | Jul 14, 2021 |
For institutional investors. Book with your work email.
Goldenrod Therapeutics, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| United States Department of Defense | Grant |
| Fannin Innovation Studio | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 26, 2026
$3.2M seed round completed.
- Oct 10, 2024
Secured $320K in grant funding.
For institutional investors. Book with your work email.
Goldenrod Therapeutics, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Goldenrod Therapeutics, Inc.'s valuation, stock price, and market status.
Is Goldenrod Therapeutics, Inc. a public or private company?
Goldenrod Therapeutics, Inc. is a private company.
What is the current stock price of Goldenrod Therapeutics, Inc.?
Goldenrod Therapeutics, Inc. is a private company, so its shares have no public market price. Caplight tracks Goldenrod Therapeutics, Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Goldenrod Therapeutics, Inc. worth (valuation)?
Valuation information for Goldenrod Therapeutics, Inc. is not publicly available.
Can I buy Goldenrod Therapeutics, Inc. stock?
Goldenrod Therapeutics, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Goldenrod Therapeutics, Inc.'s last funding round?
Goldenrod Therapeutics, Inc.'s most recent funding round was Seed on May 26, 2026.
Who are the main investors in Goldenrod Therapeutics, Inc.?
Key investors in Goldenrod Therapeutics, Inc. include Fannin Innovation Studio.
Will Goldenrod Therapeutics, Inc. IPO soon?
No public IPO plans have been announced for Goldenrod Therapeutics, Inc..
How can I track Goldenrod Therapeutics, Inc. secondary market activity?
Caplight tracks bids, offers, and trades in Goldenrod Therapeutics, Inc.'s shares on secondary markets.